AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
Hiv Aids
The first one is looking at single dose liposomal amphitheresin B in the treatment of disseminated histoplasmosis. The phase two trial that's based on this is enrolling right now. All patients got itra conazole capsules 400 milligrams a day. And I see I know we all have feelings about itra Conazole capsule. So we'll hold our peanut gallery comments, but everybody got itraconazole capsules for I can't I can't hold my peanut gallery. Go for it! You're okay. But if you only have capsules, then of course, treat your patient. If they had TB and Rifampa was going to
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode